Described are compounds of the general formula (I)
and pharmaceutically acceptable salt thereof, in which R2, R3, W,and X have the definitions illustrated in detail in the description, as beta-secretase, cathepsin D, plasmepsin II and/or HIV protease inhibitors.
The present invention relates to a phenoxypropylamine compound of the formula (I)
1
wherein each symbol is as defined in the specification, an optically active compound thereof or a pharmaceutically acceptable salt thereof and hydrates thereof, which simultaneously show selective affinity for and antagonistic activity against 5-HT
1A
receptor, as well as 5-HT reuptake inhibitory activity, and can be used as antidepressants quick in expressing an anti-depressive effect.
4-(aryl-substituted)-piperidines as neurokinin receptor antagonists
申请人:ZENECA LIMITED
公开号:EP0630887A1
公开(公告)日:1994-12-28
The present invention concerns the novel aryl substituted heterocycles of formula I, set out below,
wherein R², R³ and R⁴ have the values defined herein, which antagonize the pharmacological actions of one of the endogenous neuropeptide tachykinins at the neurokinin 2 (NK2) receptor making them useful whenever such antagonism is desired, such as in the treatment of asthma and related conditions. The invention also provides pharmaceutical compositions containing the aryl substituted heterocycles for use in such treatment, methods for their use, and processes and novel intermediates for their manufacture.